Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Inhibitor Idd 384 is an experimental small molecule compound belonging to the class of benzenesulfonamides. Its chemical formula is C19H22N2O5S and it has a molecular weight of approximately 390.5 g/mol[1][2]. The compound has been studied as a discovery agent and is not approved for clinical use in any country[1][3]. It is primarily referenced in research contexts and does not have any known approved indications or completed clinical trials as of now[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Inhibitor Idd 384.